BRIEF published on 05/19/2025 at 15:08, 1 year 2 months ago Le groupe Vanguard révèle sa position dans Primary Health Properties plc Actionnariat Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Propriétés De Santé Primaires
BRIEF published on 05/19/2025 at 15:07, 1 year 2 months ago The Vanguard Group, Inc. Discloses Interest in Assura plc Form 8.3 Takeover Code Vanguard Group Shares Disclosure Assura Plc
BRIEF published on 05/19/2025 at 15:07, 1 year 2 months ago The Vanguard Group, Inc. révèle sa participation dans Assura plc Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Divulgation Des Actions Assura Plc
BRIEF published on 05/19/2025 at 15:06, 1 year 2 months ago The Vanguard Group Discloses Significant Stake in Aviva plc Shares Disclosure Takeover Code Vanguard Group Aviva Plc
BRIEF published on 05/19/2025 at 15:06, 1 year 2 months ago Le groupe Vanguard révèle une participation significative dans Aviva plc Actions Groupe Vanguard Code De Prise De Contrôle Divulgation Aviva Plc
BRIEF published on 05/19/2025 at 15:05, 1 year 2 months ago The Vanguard Group Discloses Alphawave IP Group Position Securities Disclosure Takeover Code Vanguard Group Alphawave IP
BRIEF published on 05/19/2025 at 15:05, 1 year 2 months ago Le groupe Vanguard divulgue la position du groupe Alphawave IP Titres Groupe Vanguard Code De Prise De Contrôle Divulgation Alphawave IP
BRIEF published on 05/19/2025 at 15:05, 1 year 2 months ago Init Innovation in Traffic Systems Q1 2025 Financial Performance Revenue Growth Init Innovation Q1 2025 Results EBIT Decrease DILAX Acquisition
BRIEF published on 05/19/2025 at 15:05, 1 year 2 months ago Performance financière d'Init Innovation in Traffic Systems au premier trimestre 2025 Croissance Des Revenus Init Innovation Baisse De L'EBIT Résultats Du Premier Trimestre 2025 Acquisition De DILAX
BRIEF published on 05/19/2025 at 15:05, 1 year 2 months ago Formycon and Fresenius Kabi Achieve FDA Interchangeability Approval for FYB202/Otulfi® FDA Approval Biosimilars Formycon Fresenius Kabi Otulfi®
Published on 08/15/2026 at 00:50, 3 hours 28 minutes ago Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 4 hours 3 minutes ago Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 4 hours 33 minutes ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 4 hours 53 minutes ago NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 5 hours 18 minutes ago Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
Published on 08/14/2026 at 18:15, 10 hours 3 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/14/2026 at 16:05, 12 hours 13 minutes ago GATORADE WELCOMES AITANA BONMATÍ TO TEAM GATORADE AHEAD OF THE NEW FOOTBALL SEASON
Published on 08/14/2026 at 15:29, 12 hours 49 minutes ago Tradegate AG publishes its half-year report
Published on 08/13/2026 at 18:00, 1 day 10 hours ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 3 days 10 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 3 days 10 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 4 days 10 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 4 days 10 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
